Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Chickenpox × fludarabine × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Leukemia, Myeloid, Acute 214 Precursor Cell Lymphoblastic Leukemia-Lymphoma 127 Myelodysplastic Syndromes 125 Leukemia, Lymphocytic, Chronic, B-Cell 125 Leukemia 113 Multiple Myeloma 106 Lymphoma 105 Lymphoma, Non-Hodgkin 104 Hematologic Neoplasms 66 Recurrence 65 Melanoma 64 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 64 Hodgkin Disease 63 Lymphoma, B-Cell 56 Lymphoma, Follicular 48 Lymphoma, Mantle-Cell 47 Lymphoma, Large B-Cell, Diffuse 46 Myeloproliferative Disorders 39 Burkitt Lymphoma 38 Ovarian Neoplasms 36 Neoplasms 35 Neoplasm Metastasis 28 Lymphoma, B-Cell, Marginal Zone 28 Graft vs Host Disease 26 Leukemia, Biphenotypic, Acute 25 Breast Neoplasms 25 Carcinoma, Non-Small-Cell Lung 24 Primary Myelofibrosis 23 Neoplasms, Plasma Cell 23 Pancreatic Neoplasms 20

Interventions

fludarabine phosphate 1 fludarabine 1 Herpes Zoster Vaccine 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01953900 2026-01-23

VEGAS

Baylor College of Medicine

Phase 1 Active not recruiting

Chickenpox, Neuroblastoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡